A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
NCT02814175
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
246
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriatic Arthritis
Interventions
DRUG:
methotrexate (MTX)
BIOLOGICAL:
adalimumab (ADA)
Sponsor
AbbVie